Literature DB >> 20014751

Influence of substrate complexity on the diastereoselective formation of spiroiminodihydantoin and guanidinohydantoin from chromate oxidation.

Julia N Gremaud1, Brooke D Martin, Kent D Sugden.   

Abstract

Chromate is a human carcinogen with a poorly defined mechanism of DNA damage. In vitro and prokaryotic studies have shown that DNA damage may occur via the formation of the hydantoin lesions guanidinohydantoin (Gh) and spiroiminodihydantoin (Sp) from further oxidation of 8-oxo-7,8-dihydroguanine (8oxoG). The unusual structure of these lesions coupled with their enhanced mutagenicity make them attractive for study with regard to their role in chromate-induced cancer. We have studied the formation of Gh versus Sp and their associated diastereomers following oxidation by model Cr(V) complexes and from in situ chromate reduction by ascorbate and glutathione. Identification of the two optically assigned diastereomers of Sp (R-Sp and S-Sp) as well as the two diastereomers of Gh (Gh1 and Gh2, not yet optically assigned) was carried out using increasingly sterically hindered substrates (nucleoside --> ssDNA --> dsDNA). Lesion formation and diastereomeric preference were found to be highly oxidant- and substrate-dependent. The Ir(IV)-positive control showed a shift from near equal levels of Gh and Sp and near equal levels of all four diastereomers in the nucleoside to all Gh formation in dsDNA, with a 5-fold enhancement in Gh2 over Gh1. The two model Cr(V) complexes used in this study, Cr(V)-salen and Cr(V)-ehba, showed opposite trends going from nucleoside to dsDNA with Cr(V)-salen giving enhanced Sp formation (with mainly R-Sp formed) and the Cr(V)-ehba having an oxidation profile nearly identical to that of Ir(IV). The two chromate reduction systems, Cr(6+)/ascorbate and Cr(6+)/glutathione, designed to model the intracellular reduction of chromate, showed lower levels of oxidation in all substrates. Notable in this group was the shift in the formation of the lesions to essentially all Sp for the Cr(6+)/ascorbate system with the most sterically hindered substrate, dsDNA. These results, when coupled with the known diastereomeric preference for excision of hydantoin lesions by the hNEIL1 enzyme, show the importance of defining both levels of lesion formation and diastereomeric preference of formation with regard to their potential impact on chromate carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20014751      PMCID: PMC2821960          DOI: 10.1021/tx900362r

Source DB:  PubMed          Journal:  Chem Res Toxicol        ISSN: 0893-228X            Impact factor:   3.739


  32 in total

1.  Oxidation of 7,8-dihydro-8-oxoguanine affords lesions that are potent sources of replication errors in vivo.

Authors:  Paul T Henderson; James C Delaney; Feng Gu; Steven R Tannenbaum; John M Essigmann
Journal:  Biochemistry       Date:  2002-01-22       Impact factor: 3.162

2.  In vitro nucleotide misinsertion opposite the oxidized guanosine lesions spiroiminodihydantoin and guanidinohydantoin and DNA synthesis past the lesions using Escherichia coli DNA polymerase I (Klenow fragment).

Authors:  Olga Kornyushyna; Aym M Berges; James G Muller; Cynthia J Burrows
Journal:  Biochemistry       Date:  2002-12-24       Impact factor: 3.162

3.  Characterization of spiroiminodihydantoin as a product of one-electron oxidation of 8-Oxo-7,8-dihydroguanosine.

Authors:  W Luo; J G Muller; E M Rachlin; C J Burrows
Journal:  Org Lett       Date:  2000-03-09       Impact factor: 6.005

4.  Carcinogenic chromium(VI) induces cross-linking of vitamin C to DNA in vitro and in human lung A549 cells.

Authors:  George Quievryn; Joseph Messer; Anatoly Zhitkovich
Journal:  Biochemistry       Date:  2002-03-05       Impact factor: 3.162

5.  In vivo reduction of chromium (VI) and its related free radical generation.

Authors:  K J Liu; X Shi
Journal:  Mol Cell Biochem       Date:  2001-06       Impact factor: 3.396

6.  Guanine-specific oxidation of double-stranded DNA by Cr(VI) and ascorbic acid forms spiroiminodihydantoin and 8-oxo-2'-deoxyguanosine.

Authors:  Peter G Slade; M Katie Hailer; Brooke D Martin; Kent D Sugden
Journal:  Chem Res Toxicol       Date:  2005-07       Impact factor: 3.739

7.  Chromium(VI) exposure enhances polycyclic aromatic hydrocarbon-DNA binding at the p53 gene in human lung cells.

Authors:  Zhaohui Feng; Wenwei Hu; William N Rom; Max Costa; Moon-Shong Tang
Journal:  Carcinogenesis       Date:  2003-04       Impact factor: 4.944

8.  The hydantoin lesions formed from oxidation of 7,8-dihydro-8-oxoguanine are potent sources of replication errors in vivo.

Authors:  Paul T Henderson; James C Delaney; James G Muller; William L Neeley; Steven R Tannenbaum; Cynthia J Burrows; John M Essigmann
Journal:  Biochemistry       Date:  2003-08-12       Impact factor: 3.162

9.  Characterization of DNA-protein complexes induced in intact cells by the carcinogen chromate.

Authors:  C A Miller; M Costa
Journal:  Mol Carcinog       Date:  1988       Impact factor: 4.784

10.  The reduction of chromium (VI) to chromium (III) by glutathione: an intracellular redox pathway in the metabolism of the carcinogen chromate.

Authors:  H J Wiegand; H Ottenwälder; H M Bolt
Journal:  Toxicology       Date:  1984-12       Impact factor: 4.221

View more
  15 in total

1.  pH-Dependent Equilibrium between 5-Guanidinohydantoin and Iminoallantoin Affects Nucleotide Insertion Opposite the DNA Lesion.

Authors:  Judy Zhu; Aaron M Fleming; Anita M Orendt; Cynthia J Burrows
Journal:  J Org Chem       Date:  2015-11-24       Impact factor: 4.354

2.  Guanine oxidation product 5-carboxamido-5-formamido-2-iminohydantoin induces mutations when bypassed by DNA polymerases and is a substrate for base excision repair.

Authors:  Omar R Alshykhly; Aaron M Fleming; Cynthia J Burrows
Journal:  Chem Res Toxicol       Date:  2015-09-02       Impact factor: 3.739

3.  G-quadruplex folds of the human telomere sequence alter the site reactivity and reaction pathway of guanine oxidation compared to duplex DNA.

Authors:  Aaron M Fleming; Cynthia J Burrows
Journal:  Chem Res Toxicol       Date:  2013-03-13       Impact factor: 3.739

4.  Endonuclease and Exonuclease Activities on Oligodeoxynucleotides Containing Spiroiminodihydantoin Depend on the Sequence Context and the Lesion Stereochemistry.

Authors:  Xin Chen; Aaron M Fleming; James G Muller; Cynthia J Burrows
Journal:  New J Chem       Date:  2013-11-01       Impact factor: 3.591

5.  Biologically relevant oxidants cause bound proteins to readily oxidatively cross-link at Guanine.

Authors:  Morwena J Solivio; Dessalegn B Nemera; Larry Sallans; Edward J Merino
Journal:  Chem Res Toxicol       Date:  2012-02-06       Impact factor: 3.739

6.  Characterization of 2'-deoxyguanosine oxidation products observed in the Fenton-like system Cu(II)/H2O2/reductant in nucleoside and oligodeoxynucleotide contexts.

Authors:  Aaron M Fleming; James G Muller; Insun Ji; Cynthia J Burrows
Journal:  Org Biomol Chem       Date:  2011-03-29       Impact factor: 3.876

7.  8-Oxo-7,8-dihydro-2'-deoxyguanosine and abasic site tandem lesions are oxidation prone yielding hydantoin products that strongly destabilize duplex DNA.

Authors:  Aaron M Fleming; Cynthia J Burrows
Journal:  Org Biomol Chem       Date:  2017-10-11       Impact factor: 3.876

8.  Reconciliation of chemical, enzymatic, spectroscopic and computational data to assign the absolute configuration of the DNA base lesion spiroiminodihydantoin.

Authors:  Aaron M Fleming; Anita M Orendt; Yanan He; Judy Zhu; Rina K Dukor; Cynthia J Burrows
Journal:  J Am Chem Soc       Date:  2013-11-21       Impact factor: 15.419

9.  Structural context effects in the oxidation of 8-oxo-7,8-dihydro-2'-deoxyguanosine to hydantoin products: electrostatics, base stacking, and base pairing.

Authors:  Aaron M Fleming; James G Muller; Adrienne C Dlouhy; Cynthia J Burrows
Journal:  J Am Chem Soc       Date:  2012-08-29       Impact factor: 15.419

10.  Effect of Base-Pairing Partner on the Thermodynamic Stability of the Diastereomeric Spiroiminodihydantoin Lesion.

Authors:  Brian Gruessner; Megana Dwarakanath; Elizabeth Stewart; Yoon Bae; Elizabeth R Jamieson
Journal:  Chem Res Toxicol       Date:  2016-02-05       Impact factor: 3.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.